School of Medicine

Photo by Robert BostonWomen in Science Day brings about 100 St. Louis city high school students to campus for hands-on activities and career advice.

A lecturer from Rwanda is at the School of Medicine learning how to improve care for Rwandans who suffer from the metabolic syndromes associated with HIV/AIDS.

The University is laying plans for how it would respond if a pandemic flu strikes the St. Louis region.

Medical and graduate students who volunteer for science outreach programs don’t just help underrepresented public school students consider careers in science, according to a survey published last week in Science. They also help themselves.

A $7.7 million grant will establish a new center for asthma research at the School of Medicine. Directed by Michael J. Holtzman, M.D., the Selma and Herman Seldin Professor of Medicine, the center will investigate the cause of asthma to develop new treatments for the disease. The center’s funding comes from the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health.

The Genome Sequencing Center has been awarded a $156 million, four-year grant to use the powerful tools of DNA sequencing to unlock the secrets of cancer and other human diseases. The grant is among the largest awarded to Washington University and one of only three given by the National Human Genome Research Institute (NHGRI) to U.S. sequencing centers.

WenLeana S. Wen, 23, a current student at Washington University School of Medicine, and Aaron F. Mertz, 22, a recent alumnus from Washington University, have been named Rhodes Scholars, according to an announcement Nov. 18 by The Rhodes Trust. They are among 32 U.S. students chosen from 896 nominees for graduate study at the University of Oxford in England.

Listed below are this month’s featured news stories. • Breaking down Alzheimer’s (week of Nov. 1) • Preventing transplant rejection (week of Nov. 8) • Predicting glaucoma (week of Nov. 15) • No-incision stomach stapling (week of Nov. 22) • Organ donor health (week of Nov. 29)

School of Medicine researchers found that a malaria drug eased many symptoms of metabolic syndrome in mice. Study findings were published in the November issue of Cell Metabolism, and senior author Clay F. Semenkovich, M.D., professor of medicine and of cell biology and physiology, says funding for a clinical trial has been received.

Results from School of Medicine research suggest that a drug could save millions in health-care costs by preventing immune attacks following kidney transplants.